Palivizumab (Synagis) is indicated for the prevention of serious lower respiratory tract disease requiring hospitalization caused by respiratory syncytial virus
Aim is to treat Dyslipidemia by inhibiting PCSK9 with a novel entity
Mankind Pharma commences the commercial operations newly set-up plant in Udaipur
Lupin has been exclusively marketing these brands in the Indian market since July 2021
The company has received the Establishment Inspection Report (EIR) from the USFDA for the Pre-Approval Inspection (PAI) at a manufacturing site situated at Savli, Vadodara, Gujarat, with Zero 483 observations
Low-leveraged balance sheets, sizeable liquidity to keep credit profiles stable
This acquisition strengthens Lupin's commitment to providing superior treatment options for patients navigating the complexities of diabetes
Jeet will be a trusted partner in cardiovascular care
Shilpa Medicare Limited is the first company to receive approval for Manufacturing & Market of Pemetrexed Injection 10 ml, 50 ml, 85 ml, and 100 ml in India
Subscribe To Our Newsletter & Stay Updated
